A modified version of the 2016 ACR fibromyalgia criteria cognitive items results in stronger correlations between subjective and objective measures of cognitive impairment.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 17 05 2020
accepted: 26 10 2020
pubmed: 19 3 2021
medline: 29 6 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

In a previous study, we showed that the subjective item assessing cognitive impairment (SSS-Cog) for fibromyalgia (FM) did not correlate with the objective cognitive measures. In the current study, we describe two modifications designed to enhance this correlation: extending the SSS-cog scale from 0-3 to 1-5, and administration of a new questionnaire that specifically targets the cognitive impairments associated with FM. Sixty-two FM patients underwent a computerised cognitive assessment battery. FM symptoms were assessed on the Fibromyalgia Impact Questionnaire (FIQ); the Widespread Pain Index (WPI); the Symptom Severity Scale (SSS), the new SSS-Cog scale ranging from 1 to 5, the Beck Depression Inventory (BDI) and the new cognitive questionnaire developed by the authors. Significant correlations were found between the new SSS-Cog, the global cognitive score and all indices [Global Score r=-0.532, p=0.00; Indices: Memory r=-0.305, p=.01; Executive function r=-0.514, p=0.00; Attention r=-0.471, p=0.00; Processing Speed r=-0.468, p=0.00; Motor Skills r=-0.495, p=.00]. Significant correlations were found between the new questionnaire and the global cognitive score and all indices except the memory index [Global Score r=-0.522, p=0.00; Indices: Memory r=-0.163, p=0.212; Executive function r=-0.477, p=0.00; Attention r=-0.439, p=0.00; Processing Speed r=-0.496, p=0.00; Motor Skills r=-0.532, p=0.00]. Given the simplicity involved in extending the scale, we suggest incorporating this modification into the FM diagnostic criteria of the American College of Rheumatology (ACR).

Identifiants

pubmed: 33734966
pii: 15831
doi: 10.55563/clinexprheumatol/403mpp
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-71

Auteurs

Odelia Elkana (O)

School of Behavioral Sciences, Academic College of Tel Aviv-Yaffo, Tel Aviv, Israel. odelia.elkana@gmail.com.

Chen Yaalon (C)

School of Behavioral Sciences, Academic College of Tel Aviv-Yaffo, Tel Aviv, Israel.

Sheer Raev (S)

School of Behavioral Sciences, Academic College of Tel Aviv-Yaffo, Tel Aviv, Israel.

Noy Sobol (N)

School of Behavioral Sciences, Academic College of Tel Aviv-Yaffo, Tel Aviv, Israel.

Jacob N Ablin (JN)

Internal Medicine H, Tel-Aviv Sourasky Medical Center, Israel & Sackler School of Medicine, Tel Aviv University, Israel.

Ran Shorer (R)

Institute of Rheumatology, Tel Aviv Sourasky Medical Centre, Israel.

Valerie Aloush (V)

Tel-Aviv Sourasky Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH